Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
Recruiting · NCT05185739 · Registry updated 2024-12-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2024-12-06 | NCT05185739 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| University College, London | 222 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Addenbrooke's Hospital | Cambridge | United Kingdom | 26 |
| Beatson West of Scotland Cancer Centre | Glasgow | United Kingdom | 18 |
| Clatterbridge Cancer Centre | Liverpool | United Kingdom | 5 |
| Freeman Hospital | Newcastle upon Tyne | United Kingdom | 14 |
| Hammersmith Hospital | London | United Kingdom | 14 |
| King's College Hospital | London | United Kingdom | 45 |
| Queen Elizabeth Hospital | Birmingham | United Kingdom | 23 |
| Royal Free Hospital | London | United Kingdom | 24 |
| St James's Hospital | Leeds | United Kingdom | 2 |
| The Christie NHS Foundation Trust | Manchester | United Kingdom | 40 |
| Western General Hospital | Edinburgh | United Kingdom | 52 |